Back to search

Article

Functional and signaling characterization of the neutrophil FPR2 selective agonist Act-389949

2019-03-08

Abstract excerpt

Despite the steadily increased numbers of formyl peptide receptor (FPR) ligands identified over the years, few have been characterized in studies using animal disease models and even less have entered clinical trials in human subjects. A small-molecule compound, Act-389949, was however recently tested in a phase I clinical trial and found to be safe and well tolerated in healthy human subjects. The desired anti-in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6c6b6e2f-0293-5bbb-9378-6a655baaed3f
DOI
10.1101/571604
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Functional and signaling characterization of the neutrophil FPR2 selective agonist Act-389949DOI 10.1101/571604
Select a neighboring publication to make it the new centre.